HUT63392A - Pyrazole derivatives, their production and medical preparatives containing them - Google Patents
Pyrazole derivatives, their production and medical preparatives containing themInfo
- Publication number
- HUT63392A HUT63392A HU9300309A HU9300309A HUT63392A HU T63392 A HUT63392 A HU T63392A HU 9300309 A HU9300309 A HU 9300309A HU 9300309 A HU9300309 A HU 9300309A HU T63392 A HUT63392 A HU T63392A
- Authority
- HU
- Hungary
- Prior art keywords
- hydroxy
- acyl
- alkyl
- production
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/16—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929202442A GB9202442D0 (en) | 1992-02-05 | 1992-02-05 | Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same |
GB929220427A GB9220427D0 (en) | 1992-09-28 | 1992-09-28 | Pyrazole derivatives processes for preparation thereof and pharmaceutical composition comprising the same |
Publications (2)
Publication Number | Publication Date |
---|---|
HU9300309D0 HU9300309D0 (en) | 1993-04-28 |
HUT63392A true HUT63392A (en) | 1993-08-30 |
Family
ID=26300272
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9300309A HUT63392A (en) | 1992-02-05 | 1993-02-05 | Pyrazole derivatives, their production and medical preparatives containing them |
HU95P/P00347P HU211509A9 (en) | 1992-02-05 | 1995-06-22 | Pyrazole derivatives, pharmaceutical compositions comprising the same and processes for preparation thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU95P/P00347P HU211509A9 (en) | 1992-02-05 | 1995-06-22 | Pyrazole derivatives, pharmaceutical compositions comprising the same and processes for preparation thereof |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0554829B1 (hu) |
JP (1) | JPH05246997A (hu) |
KR (1) | KR100252151B1 (hu) |
CN (1) | CN1045767C (hu) |
AT (1) | ATE217613T1 (hu) |
AU (1) | AU663149B2 (hu) |
CA (1) | CA2088835A1 (hu) |
DE (1) | DE69331920T2 (hu) |
ES (1) | ES2173875T3 (hu) |
HU (2) | HUT63392A (hu) |
IL (1) | IL104311A (hu) |
MX (1) | MX9300579A (hu) |
PH (1) | PH30916A (hu) |
RU (1) | RU2128172C1 (hu) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2690440B1 (fr) * | 1992-04-27 | 1995-05-19 | Rhone Poulenc Agrochimie | Arylpyrazoles fongicides. |
FR2711140B1 (fr) * | 1993-10-12 | 1996-01-05 | Sanofi Sa | 1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant. |
ES2193609T3 (es) * | 1993-11-30 | 2003-11-01 | Searle & Co | Pirazolil-bencenosulfonamidas sustituidas y su uso como inhibidores de la ciclooxigenasa ii. |
US6492411B1 (en) | 1993-11-30 | 2002-12-10 | G. D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation |
US6716991B1 (en) | 1993-11-30 | 2004-04-06 | G. D. Searle & Co. | Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation |
US5466823A (en) * | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
US5475018A (en) | 1993-11-30 | 1995-12-12 | G. D. Searle & Co. | 1,5-diphenyl pyrazole compounds for treatment of inflammation |
US6613789B2 (en) | 1994-07-28 | 2003-09-02 | G. D. Searle & Co. | Heterocyclo-substituted imidazoles for the treatment of inflammation |
US5616601A (en) * | 1994-07-28 | 1997-04-01 | Gd Searle & Co | 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation |
JPH10509140A (ja) * | 1994-11-08 | 1998-09-08 | エーザイ株式会社 | ピラゾール誘導体 |
EP0828717B1 (en) * | 1995-05-25 | 2002-09-04 | G.D. SEARLE & CO. | Method of preparing 3-haloalkyl-1h-pyrazoles |
US5756529A (en) * | 1995-09-29 | 1998-05-26 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies |
GB9520584D0 (en) * | 1995-10-09 | 1995-12-13 | Fujisawa Pharmaceutical Co | Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same |
ID21775A (id) * | 1996-10-25 | 1999-07-22 | Yoshitomi Pharmaceutical | Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya |
CZ225699A3 (cs) * | 1996-12-23 | 2000-09-13 | Du Pont Pharmaceuticals Company | Dusíkaté heteroaromatické sloučeniny jako inhibitory faktoru Xa |
ZA985247B (en) * | 1997-06-19 | 1999-12-17 | Du Pont Merck Pharma | Guanidine mimics as factor Xa inhibitors. |
US6339099B1 (en) | 1997-06-20 | 2002-01-15 | Dupont Pharmaceuticals Company | Guanidine mimics as factor Xa inhibitors |
AU750356B2 (en) * | 1997-09-24 | 2002-07-18 | Fujisawa Pharmaceutical Co., Ltd. | 1,5-diphenylpyrazole derivatives |
AUPO941497A0 (en) * | 1997-09-24 | 1997-10-16 | Fujisawa Pharmaceutical Co., Ltd. | Novel compounds |
IL136637A0 (en) * | 1997-12-22 | 2001-06-14 | Du Pont Pharm Co | Nitrogen containing heteroaromatics with ortho-substituted pi's as factor xa inhibitors |
US6271237B1 (en) | 1997-12-22 | 2001-08-07 | Dupont Pharmaceuticals Company | Nitrogen containing heteromatics with ortho-substituted P1s as factor Xa inhabitors |
DE19816880A1 (de) * | 1998-04-17 | 1999-10-21 | Boehringer Ingelheim Pharma | Neue Diphenyl-substituierte 5-Ring-Heterocyclen, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel |
KR19990080440A (ko) * | 1998-04-17 | 1999-11-05 | 성재갑 | 신규한 피라졸 유도체 |
KR19990085450A (ko) * | 1998-05-18 | 1999-12-06 | 성재갑 | 피라졸 구조를 갖는 새로운 mek 단백질 저해제 |
US6294558B1 (en) | 1999-05-31 | 2001-09-25 | Pfizer Inc. | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
US6727238B2 (en) | 1998-06-11 | 2004-04-27 | Pfizer Inc. | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
DE19904391A1 (de) * | 1999-02-04 | 2000-08-10 | Bayer Ag | Pyrazol-Alkylamide |
MXPA02002111A (es) * | 1999-08-27 | 2002-10-31 | Abbott Lab | Compuestos de sulfonilfenilpirazol utiles como inhibidores de cox-2. |
CA2392931A1 (en) | 1999-12-03 | 2001-06-07 | Pfizer Products Inc. | Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
DK1104758T3 (da) | 1999-12-03 | 2003-10-20 | Pfizer Prod Inc | Acetylenderivativer som anti-inflammatoriske/analgesiske lægemidler |
ES2208227T3 (es) | 1999-12-03 | 2004-06-16 | Pfizer Products Inc. | Compuestos de heteroarilfenilpirazol como agentes antiinflamatorios/analgesicos. |
DE60001623T2 (de) | 1999-12-03 | 2003-12-18 | Pfizer Prod Inc | Sulfamoylheteroarylpyrazolverbindungen zur Verwendung als analgetisches/entzündungshemmendes Mittel |
AU4589701A (en) * | 2000-03-24 | 2001-10-08 | Cocensys Inc | Aryl substituted pyrazoles, triazoles and tetrazoles, and the use thereof |
ES2241964T3 (es) | 2001-07-05 | 2005-11-01 | Pfizer Products Inc. | Heterocicloalquilsulfufonilpirazoles como agentes antiinflamatorios/abnalgesicos. |
GT200200183A (es) | 2001-09-28 | 2003-05-23 | Procedimiento para preparar derivados de heterocicloalquilsulfonil pirazol | |
WO2003037336A1 (en) | 2001-11-02 | 2003-05-08 | Pfizer Products Inc. | 1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile derivatives and other compounds as cyclooxygenase inhibitors for the treatment of arthritis, neurodegeneration and colon cancer |
JP2005532333A (ja) | 2002-05-24 | 2005-10-27 | ファルマシア・コーポレーション | ジアリールピラゾールの合成 |
EP1539679A4 (en) | 2002-06-28 | 2007-07-04 | Nitromed Inc | OXIM- AND / OR HYDRAZO-CONTAINING, NITROSED AND / OR NITROSYLATED CYCLOOXIGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND USE METHODS |
US20060079566A1 (en) | 2003-10-03 | 2006-04-13 | Ching-Shih Chen | PDK-1/Akt signaling inhibitors |
DK1696907T3 (da) * | 2003-10-03 | 2013-06-24 | Univ Ohio State Res Found | PDK-1/AKT Signalinhibitorer |
JP2007518686A (ja) * | 2003-10-17 | 2007-07-12 | 田辺製薬株式会社 | 高コンダクタンス型カルシウム感受性kチャネル開口薬 |
US8039502B2 (en) | 2007-07-24 | 2011-10-18 | The Ohio State University Research Foundation | Anti-infective agents against intracellular pathogens |
RU2480456C2 (ru) * | 2007-11-13 | 2013-04-27 | Тайсо Фармасьютикал Ко., Лтд. | Фенилпиразольные производные |
DE102008015032A1 (de) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte Pyrazolamide und ihre Verwendung |
DE102008015033A1 (de) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung |
DE102008062878A1 (de) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte Furancarboxamide und ihre Verwendung |
DE102008062863A1 (de) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung |
US20120108823A1 (en) | 2009-04-22 | 2012-05-03 | The Ohio State University Research Foundation | Anti-francisella agents |
DE102009036604A1 (de) | 2009-07-30 | 2011-02-03 | Aicuris Gmbh & Co. Kg | Substituierte Bis-Arylpyrazolamide mit terminaler primärer Amidfunktionalisierung und ihre Verwendung |
KR101911105B1 (ko) * | 2010-09-21 | 2018-10-23 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 제약 조성물 |
DE102011055815A1 (de) | 2011-11-29 | 2013-05-29 | Aicuris Gmbh & Co. Kg | Carboxamid-substituierte Heteroaryl-Pyrazole und ihre Verwendung |
DE102012016908A1 (de) | 2012-08-17 | 2014-02-20 | Aicuris Gmbh & Co. Kg | Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1130808A (en) * | 1979-10-05 | 1982-08-31 | Ronald G. Micetich | 3-(or 5-) trifluoromethyl-1-aryl pyrazoles |
US4826868A (en) * | 1986-05-29 | 1989-05-02 | Ortho Pharmaceutical Corporation | 1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use |
AU611437B2 (en) * | 1987-05-29 | 1991-06-13 | Ortho Pharmaceutical Corporation | Pharmacologically active 2- and 3-substituted (1',5'-diaryl-3-pyrazolyl)-n-hydroxypropanamides and method for synthesizing the same |
PH27357A (en) * | 1989-09-22 | 1993-06-21 | Fujisawa Pharmaceutical Co | Pyrazole derivatives and pharmaceutical compositions comprising the same |
FR2665898B1 (fr) * | 1990-08-20 | 1994-03-11 | Sanofi | Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
JPH08181316A (ja) * | 1994-12-22 | 1996-07-12 | Mitsubishi Electric Corp | 半導体装置及びその製造方法 |
-
1993
- 1993-01-05 IL IL104311A patent/IL104311A/xx not_active IP Right Cessation
- 1993-01-26 JP JP5010379A patent/JPH05246997A/ja active Pending
- 1993-02-02 AT AT93101569T patent/ATE217613T1/de not_active IP Right Cessation
- 1993-02-02 DE DE69331920T patent/DE69331920T2/de not_active Expired - Fee Related
- 1993-02-02 EP EP93101569A patent/EP0554829B1/en not_active Expired - Lifetime
- 1993-02-02 AU AU32174/93A patent/AU663149B2/en not_active Ceased
- 1993-02-02 ES ES93101569T patent/ES2173875T3/es not_active Expired - Lifetime
- 1993-02-03 MX MX9300579A patent/MX9300579A/es not_active IP Right Cessation
- 1993-02-04 CN CN93101069A patent/CN1045767C/zh not_active Expired - Fee Related
- 1993-02-04 CA CA002088835A patent/CA2088835A1/en not_active Abandoned
- 1993-02-04 KR KR1019930001455A patent/KR100252151B1/ko not_active IP Right Cessation
- 1993-02-04 RU RU93004484A patent/RU2128172C1/ru active
- 1993-02-05 HU HU9300309A patent/HUT63392A/hu unknown
- 1993-06-06 PH PH45530A patent/PH30916A/en unknown
-
1995
- 1995-06-22 HU HU95P/P00347P patent/HU211509A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
KR100252151B1 (ko) | 2000-09-01 |
JPH05246997A (ja) | 1993-09-24 |
KR930017873A (ko) | 1993-09-20 |
PH30916A (en) | 1997-12-23 |
IL104311A (en) | 1997-07-13 |
EP0554829A3 (en) | 1994-06-08 |
EP0554829A2 (en) | 1993-08-11 |
HU211509A9 (en) | 1995-11-28 |
AU663149B2 (en) | 1995-09-28 |
CN1075959A (zh) | 1993-09-08 |
IL104311A0 (en) | 1993-05-13 |
EP0554829B1 (en) | 2002-05-15 |
HU9300309D0 (en) | 1993-04-28 |
ES2173875T3 (es) | 2002-11-01 |
RU2128172C1 (ru) | 1999-03-27 |
CA2088835A1 (en) | 1993-08-06 |
MX9300579A (es) | 1993-09-30 |
DE69331920T2 (de) | 2002-09-26 |
AU3217493A (en) | 1993-08-12 |
CN1045767C (zh) | 1999-10-20 |
ATE217613T1 (de) | 2002-06-15 |
DE69331920D1 (de) | 2002-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9300309D0 (en) | Pyrazole derivatives, their production and medical preparatives containing them | |
IL95675A0 (en) | Pyrazole derivatives,processes for preparation thereof and pharmaceutical compositions containing the same | |
TW260667B (hu) | ||
IL109615A0 (en) | Polypeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL107426A0 (en) | Heterocyclic compounds, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
HU9500240D0 (en) | New prolin-amide derivatives and pharmaceutical compositions containing them as active component | |
HUT64336A (en) | Methods for producing new thiazole-benzofurane derivatives and pharmaceutical preparatives containing them | |
AU617918B2 (en) | 2-aminopyrimidinone derivatives | |
AU6052594A (en) | New heterocyclic compounds | |
AU630575B2 (en) | Benzodiazepine derivatives | |
CA2140781A1 (en) | Pharmocologically active .alpha.-¬tertiary-aminomethyl|- benzenemethanol derivatives | |
HUT51622A (en) | Process for producing 3-piperidinole-indazole derivatives and pharmaceutical preparations having effect against high blood pressure containing these compounds as active substance | |
TW275629B (hu) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFD9 | Temporary protection cancelled due to non-payment of fee |